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Deletion of Late Cornified Envelope 3B and 3C Genes
Is Not Associated with Atopic Dermatitis
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Giuseppe Novelli5, Martin Den Heijer6, Elke Rodriguez4, Thomas Illig7, Eva Riveira-Munoz8,
Linda E. Campbell9, Jess Tyson10, Emma N. Dannhauser10, Gra´inne M. O’Regan2, Elena Galli11,
Norman Klopp7, Gerard H. Koppelman12, Natalija Novak13, Xavier Estivill8,14, W.H. Irwin McLean2,
Dirkje S. Postma15, John A.L. Armour10 and Joost Schalkwijk1
Atopic dermatitis (AD) and psoriasis are common skin diseases characterized by cutaneous inflammation and
disturbed epidermal differentiation. Genome-wide analyses have shown overlapping susceptibility loci, such as
the epidermal differentiation complex on chromosome 1q21. Recently, a deletion on 1q21 (LCE3C_LCE3B-del),
comprising LCE3B and LCE3C, two members of the late cornified envelope (LCE) gene cluster, was found to be
associated with psoriasis. Although the mechanistic role of LCE proteins in psoriasis has not been identified,
these proteins are putatively involved in skin barrier formation and repair. Considering the potential genetic
overlap between the two diseases and the recent finding that mutations in the skin barrier protein filaggrin are
associated with AD, we investigated a possible association between LCE3C_LCE3B-del and AD. Evaluation of
four different cohorts of European ancestry, containing a total of 1075 AD patients and 1658 controls, did not
provide evidence for such an association. Subgroup analysis did not reveal an association with concomitant
asthma. Our data suggest that the potential roles of skin barrier defects in the pathogenesis of AD and psoriasis
are based on distinct genetic causes.
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INTRODUCTION
Atopic dermatitis (AD) and psoriasis are clinically distinct,
chronic inflammatory skin diseases with a strong genetic
basis (Leung and Bieber, 2003; Bowcock and Cookson, 2004;
Krueger and Bowcock, 2005). Several genome-wide analyses
have been performed to discover genetic factors contributing
to AD and psoriasis (Cookson, 2004). These analyses
have revealed chromosomal regions harboring possible
susceptibility loci for both diseases, including chromosomal
regions 1q21, 3q21, 17q25, and 20p12. These findings
suggested that AD and psoriasis could share some contribut-
ing genetic factors, but none of these have been identified to
date (Willis-Owen et al., 2007).
Although both diseases are generally regarded as immune-
mediated conditions, recent genetic studies have indicated
the importance of inherited abnormalities of epidermis-
expressed genes as a primary cause (Magert et al., 1999;
Chavanas et al., 2000; Cookson, 2004; Palmer et al., 2006;
Hollox et al., 2008; De Cid et al., 2009). These findings are in
line with the concept of inflammatory epithelial disease,
which was coined previously for a number of conditions that
were associated with epithelium-expressed genes and im-
munological mechanisms (Cookson, 2004). The shared locus
on chromosome 1q21 overlies the epidermal differentiation
complex (EDC), a cluster of genes encoding proteins found in
the uppermost layers of the epidermis, which are of great
importance for keratinocyte differentiation and skin barrier
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maintenance (Mischke et al., 1996). Genes located in the
EDC include loricrin, involucrin, filaggrin (FLG), the small
proline-rich protein genes, the S100 genes, and the late
cornified envelope (LCE) genes. Null mutations in the FLG
gene have been identified as a remarkably strong and widely
replicated risk factor for AD and led to a paradigm shift,
placing the barrier function of the skin into the center of the
pathogenetic concepts (Irvine and McLean, 2006; Palmer
et al., 2006; Smith et al., 2006; Weidinger et al., 2006, 2008;
Fallon et al., 2009). Interestingly, also the cytokine environ-
ment associated with AD (Th2 cytokines) appears to
contribute to compromised skin barrier function, as IL-4
and IL-13 suppress FLG gene expression (Howell et al.,
2007). In contrast to the genetic findings for AD, no
associations of FLG null alleles with psoriasis could be
shown (Huffmeier et al., 2007; Zhao et al., 2007).
Although FLG mutations account for 13% of the popula-
tion attributable risk in AD (O’Regan et al., 2008), they only
partially explain the linkage signal of AD to the EDC (Morar
et al., 2007). In addition, in a recent large-scale genome-wide
association study, evidence for additional AD risk factors in
the EDC, apart from prevalent FLG mutations, was obtained
(Esparza-Gordillo et al., 2009).
Apart from single-nucleotide polymorphisms (SNPs), DNA
copy number variation represents a considerable source of
human genetic diversity (Redon et al., 2006; Korbel et al.,
2007; Kidd et al., 2008). De Cid et al. (2009) discovered that
the deletion of two genes of the LCE gene family, LCE3B and
LCE3C (annotated as LCE3C_LCE3B-del), located in the EDC,
was significantly associated with psoriasis in individuals of
European ancestry. This finding has recently been replicated
by an independent study in German psoriasis patients
(Huffmeier et al., 2009). In addition, in an independent
genome-wide association study of a Chinese cohort, associa-
tion with SNPs in a strong linkage disequilibrium with the
deletion were identified as risk factors for psoriasis (Zhang
et al., 2009). LCE proteins are incorporated in the cornified
envelope during epidermal differentiation, as shown by
Marshall et al. (2001). The work by De Cid et al. (2009)
suggests that one of the psoriasis-associated genes, LCE3C, is
involved in repair of skin barrier function, as its expression is
only induced upon epidermal activation.
These observations together with the role of skin barrier
maintenance in both diseases prompted us to investigate a
possible genetic association between the LCE3C_LCE3B-del
allele and AD. Our analysis of four European case–control
cohorts, a total of over 2500 samples, however, did not
support such an association.
RESULTS
Analysis of association of LCE3C_LCE3B-del with AD
To investigate a possible association of AD with the deletion
of the LCE3B and LCE3C genes, we genotyped four European
case–control cohorts, consisting of adult cases from The
Netherlands and Germany and children with AD from Ireland
and Italy (see Table 1 and Supplementary Information
for cohort summaries and description). The Dutch, German,
and Irish cohort were genotyped by using the direct
PCR-based method described by De Cid et al. (2009). The
Italian cohort was genotyped by analyzing SNP rs4112788,
which can be used as a proxy for the deletion as it is in
strong linkage disequilibrium with the deletion (r2¼0.928
and D0 ¼0.988) (De Cid et al., 2009). In the different
control groups, frequencies of the LCE3C_LCE3B-del allele
varied between 59 and 66%. This heterogeneity of the
control groups in different ethnic backgrounds was already
known from our previous study (De Cid et al., 2009). In the
Dutch cohort, we found a significantly higher frequency
of the LCE3C_LCE3B-del allele in AD patients (66%)
compared with healthy controls (59%) (Supplementary Table
1). Further analysis were performed by using logistic
regression models, in which the wt/wt genotype (homozy-
gous for the undeleted LCE3C_LCE3B allele) was used as
reference category. For the Dutch cohort, these analyses
showed only for the del/del genotype (homozygous for the
LCE3C_LCE3B deletion) a significant association with AD
(P¼0.022), corresponding odds ratio (OR) of 1.71 (95%
confidence interval (95% CI): 1.08–2.70). For the del/wt
genotype (heterozygous for the LCE3C_LCE3B deletion) no
association with AD was found (P¼0.420) (Table 2). In none
of the other cohorts a significant association with AD and the
del/del genotype was found (Table 2). For the del/wt
genotype a significant association was found in the German
cohort (P¼0.018), which was in the opposite direction to the
Dutch cohort (OR 0.52, 95% CI: 0.31–0.90). When all
cohorts were combined to increase statistical power (Table 2,
combined power is 1.0), no significant association was
detected for either of the two genotypes (P¼0.665 and
0.945). It has to be noted, however, that for the del/del
analysis significant heterogeneity was found between
the cohorts.
Table 1. Cohort characteristics
Population Phenotype N (%) Ratio
Mean age
(SD) % Male
The Netherlands Control 386 48 (16) 56
AD 295 1.3 34 (9.3) 33
ADþ asthma 172 (58) 2.2 34 (8.8) 30
German replicate Control 248 39 (13) 36
AD 258 1.0 38 (16) 38
ADþ asthma 83 (32) 3.0 36 (15) 36
Irish replicate Control 578 36 (3.5) 30
AD 314 2.1 4.0 (3.8) 64
ADþ asthma 98 (31) 5.9 7.8 (4.3) 64
Italian replicate Control 446 42 (15) 62
AD 208 1.5 8.9 (6.2) 60
ADþ asthma 38 (18) 11 13 (6.5) 79
Atopic dermatitis (AD)þ asthma is a subgroup of the AD cohort. (%) Is the
percentage of the total AD cohort, which is present in the ADþ asthma
cohort. Ratio, control/case ratio.
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Analysis of association of LCE3C_LCE3B-del with ADþ asthma
or serum IgE
Subgroup analysis of the different AD cohorts revealed that
the Dutch cohort, which showed a significant association,
contained a higher percentage of patients with concomitant
asthma (58 versus 18–32% in the other cohorts). In this
cohort, we found a significantly higher frequency of the
LCE3C_LCE3B-del allele in the subgroup of ADþ asthma
patients (66%) compared with healthy controls (59%)
(Supplementary Table 2). In contrast, logistic regression
models, again using wt/wt as reference, showed no associa-
tion for the del/wt genotype with ADþ asthma (P¼0.350,
OR 1.30, 95% CI: 0.75–2.26, Table 3). For the del/del
genotype an association of borderline significance was found
for ADþ asthma (P¼ 0.057, OR 1.71, 95% CI: 0.98–2.98)
(Table 3). Stratification for asthma in the other cohorts,
however, did not reveal significant associations between
ADþ asthma and LCE3C_LCE3B-del (Table 3). For the del/wt
genotype an association of borderline significance for
LCE3C_LCE3B-del and ADþ asthma was found in the Ger-
man cohort (P¼0.059), which was in the opposite direction
to the Dutch cohort (OR 0.50, 95% CI: 0.24–1.03).
Combining all ADþ asthma data from the four cohorts,
to increase statistical power (see Table 3 combined power
is 1.0), revealed no significant association of asthmaþ
AD and the LCE3B_LCE3C-del allele (n¼ 2049, P¼0.416
and 0.103 for the del/wt and del/del genotypes, respectively,
Table 3).
As a region on 1q21 in close proximity to the LCE cluster
was previously reported to be associated with total serum IgE
levels (Sharma et al., 2007), we further examined the
association of the LCE3C_LCE3B-del allele with total serum
Table 2. Frequencies of the different LCE3B_LCE3C genotypes and analysis of the association with AD
LCE3C_LCE3B del/wt del/del
Population Phenotype Samples del/del wt/del wt/wt OR 95% CI P-value OR 95% CI P-value Power
The Netherlands Control 386 141 (0.36) 176 (0.46) 69 (0.18)
N=681 AD 295 136 (0.46) 120 (0.41) 39 (0.13) 1.21 (0.76–1.90) 0.420 1.71 (1.08–2.70) 0.022 0.92
German replicate Control 248 90 (0.36) 131 (0.53) 27 (0.11)
N=506 AD 258 99 (0.38) 114 (0.44) 45 (0.17) 0.52 (0.31–0.90) 0.018 0.66 (0.38–1.15) 0.143 0.82
Irish replicate Control 578 256 (0.44) 250 (0.43) 72 (0.13)
N=892 AD 314 118 (0.38) 148 (0.47) 48 (0.15) 0.89 (0.58–1.35) 0.578 0.69 (0.45–1.06) 0.089 0.96
Italian replicate Control 446 156 (0.35) 211 (0.47) 79 (0.18)
N=654 AD 208 71 (0.34) 106 (0.51) 31 (0.15) 1.28 (0.80–2.06) 0.309 1.16 (0.70–1.92) 0.562 0.87
All* Control 1,658 643 (0.39) 768 (0.46) 247 (0.15)
N=2,733 AD 1,075 424 (0.39) 488 (0.46) 163 (0.15) 0.95 (0.76–1.20) 0.665 0.99 (0.78–1.26) 0.945** 1.0
OR 95% CI, odds ratio and 95% confidence interval for del/wt and del/del LCE3C_LCE3B genotypes and atopic dermatitis (AD) obtained by logistic
regression using wt/wt as a reference; *Values presented in the table are adjusted by population. For All, del/del **significant heterogenity was found.
Table 3. Frequencies of the different LCE3B_LCE3C genotypes and analysis of the association with ADþ asthma
LCE3C_LCE3B del/wt del/del
Population Phenotype Samples del/del wt/del wt/wt OR 95% CI P-value OR 95% CI P-value Power
The Netherlands Control 386 141 (0.36) 176 (0.46) 69 (0.18)
N=558 ADþ asthma 172 77 (0.45) 73 (0.42) 22 (0.13) 1.30 (0.75–2.26) 0.350 1.71 (0.98–2.98) 0.057 0.80
German replicate Control 248 90 (0.36) 131 (0.53) 27 (0.11)
N=331 ADþ asthma 83 32 (0.39) 36 (0.43) 15 (0.18) 0.50 (0.24–1.03) 0.059 0.64 (0.30–1.35) 0.243 0.50
Irish replicate Control 578 256 (0.44) 250 (0.43) 72 (0.13)
N=676 ADþ asthma 98 42 (0.43) 47 (0.48) 9 (0.09) 1.50 (0.70–3.22) 0.292 1.31 (0.61–2.82) 0.487 0.64
Italian replicate Control 446 156 (0.35) 211 (0.47) 79 (0.18)
N=484 ADþ asthma 38 17 (0.45) 18 (0.47) 3 (0.08) 2.25 (0.64–7.84) 0.204 2.87 (0.82–10.1) 0.100 0.30
All* Control 1,658 643 (0.39) 768 (0.46) 247 (0.15)
N=2,049 ADþ asthma 391 168 (0.43) 174 (0.44) 49 (0.13) 1.16 (0.81–1.66) 0.416 1.35 (0.94–1.94) 0.103 1.0
OR 95% CI, odds ratio and 95% confidence interval for del/wt and del/del LCE3C_LCE3B genotypes and atopic dermatitis (AD)þ asthma obtained by
logistic regression using wt/wt as a reference; *Values presented in the table are adjusted by population.
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IgE levels in our Dutch cohort. As expected, the cases (mean
total IgE 115 kU l1) had significantly higher total IgE serum
levels than the controls (mean total IgE 20.7 kU l1,
Po0.001). However, analysis of variance did not show
differences in IgE serum levels for the different genotypes
within the patient groups separately and overall (P¼0.351,
data not shown).
DISCUSSION
Our analysis of the association of LCE3C_LCE3B-del and AD
showed varying results in the different cohorts. A significant
positive association was found in the Dutch cohort, whereas
a weak association in the opposite direction was found for the
del/wt genotype in the German cohort. The apparent
association found in the Dutch cohort might be due to
population heterogeneity, or could be a false-positive finding
resulting from small cohort sizes. Because of the high linkage
disequilibrium between SNP rs4112788 and LCE3B_LCE3C-
del (r2¼0.928 and D0 ¼ 0.988), although admittedly not
absolute, we decided to include both the LCE3C_LCE3B-del
and the rs4112788 results (Italian data set) in our overall
analysis. On the basis of the combined results, we conclude
that there is no evidence for association of LCE3C_LCE3B-del
and AD in individuals of European ancestry. These results
underline the importance of replication studies. Similarly, we
did not detect an association of LCE3C_LCE3B-del and
ADþ asthma. It has to be noted, however, that the power
to detect an effect for ADþ asthma was smaller than that for
AD alone. For the ADþ asthma phenotypes, the power of the
individual cohorts is rather small (Table 3); however, the
power of combined analysis both in AD and ADþ asthma is
1.0. It should be noted that for a part of the Dutch control
cohort, the Irish and Italian control cohorts no information
about asthma status was available, which may limit the
interpretation of our analysis.
Previous studies on FLG and LCE3C_LCE3B-del have
indicated that polymorphisms and mutations in genes
encoding skin barrier proteins make a sizeable contribution
to the genetic basis of both AD (estimated population
attributable risk of FLG is 13% (O’Regan et al., 2008)) and
psoriasis (estimated population attributable risk of LCE3C_
LCE3B-del is 21% (De Cid et al., 2009)). For AD it is very
likely that FLG mutations directly affect barrier function of
normal skin and contribute to percutaneous antigen priming
and the subsequent immunological sequelae leading to overt
disease (Fallon et al., 2009). In the case of psoriasis, the role
of the deleted LCE genes is less clear as they are not normally
expressed in intact skin, but only induced upon activation.
Preliminary findings from our laboratory indicate that this is
also true for LCE3B and LCE3C expression in AD (data not
shown). It was recently suggested that other genes of the EDC
contribute to AD, and clearly there are many other plausible
candidate genes in this region, which may on their own or
through interaction with FLG lead to barrier dysfunction and
AD (Morar et al., 2007). As there was no convincing
association between LCE3C_LCE3B-del and AD, we did not
further investigate a possible interaction with FLG null alleles.
We conclude that, despite the shared locus on chromosome
1, the psoriasis-associated deletion of LCE3 genes does not
contribute to AD. Our data indicate that the potential roles of
skin barrier defects in the pathogenesis of AD and psoriasis
are based on distinct genetic causes.
MATERIALS AND METHODS
Study populations
A total of 1075 patients and 1658 controls of European origin from
four cohorts was investigated. Basic characteristics of the study
cohorts are shown in Table 1, and a detailed description of the study
population is given in the Supplementary Information. In all studies
informed consent was obtained, and all studies have been approved
by the local ethical committees: for the Netherlands, The medical
ethics committee of the University Medical Center Groningen and
‘‘Commissie Mensgebonden Onderzoek Arnhem-Nijmegen’’; for
Germany, ‘‘Bayerische Landesa¨rtzekammer’’ Munich and the ethics
committee of the University of Bonn; for Italy, the medical ethics
committee ‘‘Policlinico Tor Vergata’’; and for Ireland, The Research
Ethics Committees of Our Lady’s Children’s Hospital Crumlin (cases)
and Trinity College Dublin (Trinity Biobank controls). The investiga-
tions were conducted according to the Declaration of Helsinki
principles.
Genotyping
The Dutch, German, and Irish cohort were genotyped by using the
direct PCR-based method described by De Cid et al. (2009). The
Italian cohort was genotyped by analyzing SNP rs4112788, which
was shown to be in a strong linkage disequilibrium with the deletion
(r2¼ 0.93 and D0 ¼ 0.99) (De Cid et al., 2009). Genotyping was
successful in 98.1% of probands. We did not observe significant
evidence for deviation from Hardy–Weinberg equilibrium in any of
the study groups.
Statistical analysis
Descriptive statistics for quantitative values are given as means±
standard deviation. The observed genotype frequencies were
compared with the expected Hardy–Weinberg distribution by w2-
test. Logistic regression models were used to assess the genetic effect
of the LCE3C_LCE3B-del allele on AD risk: data from co-dominant
and genotype-specific models were calculated (for results from co-
dominant models, see Supplementary Tables 1 and 2). Genotype-
specific models were used in the main text of this article, as these
models are biologically relevant. The presented data in the main text
are derived from models that are unadjusted for age and sex.
Unadjusted OR and 95% CI were calculated using homozygosity for
the undeleted allele (wt/wt) as a reference category. Overall-values
present in the tables are adjusted by population. The sex-adjusted
analysis for the Italian and Irish cohorts are present in Supplementary
Table 3. To test if the cohorts show heterogeneity, the Cochran–
Mantel–Haenszel statistics were performed, for del/del compared with
wt/wt genotypes significant differences were found (P¼ 0.003). Values
for total serum IgE levels were only available from the Dutch cohort.
These values were first log-transformed and comparisons were carried
out using one-way analysis of variance. The statistical analysis was
performed using SPSS software 16.0 (SPSS, Chicago, IL). Power
calculations were performed using Stata Software 10.0 (StataCorp LP,
College Station, TX), assumptions in the power analysis (OR of 1.7)
were derived from our previous study (De Cid et al., 2009).
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